RIZATRIPTAN

RIZATRIPTAN was reported 10325 times

RIZATRIPTAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PARASYMPATHETIC NERVE INJURY 6 0.6000
1 GRANULOSA CELL TUMOUR OF THE TESTIS 4 0.5714
2 BROAD LIGAMENT TEAR 4 0.5000
3 PALATE INJURY 10 0.1205
4 POSTNATAL GROWTH RESTRICTION 12 0.0916
5 CONGENITAL ACROCHORDON 4 0.0615
6 PHLEBOLITH 10 0.0592
7 HYPERMOBILITY SYNDROME 24 0.0482
8 NEOVASCULARISATION 12 0.0456
9 CERVICOGENIC HEADACHE 5 0.0368
10 ALLERGY TO IMMUNOGLOBULIN THERAPY 4 0.0367
11 PINEAL GLAND CYST 5 0.0357
12 PNEUMONITIS ASPIRATION 12 0.0351
13 MEDICATION OVERUSE HEADACHE 23 0.0269
14 ATRIOVENTRICULAR SEPTAL DEFECT 11 0.0234
15 MIGRAINE WITHOUT AURA 7 0.0233
16 HERPES SIMPLEX REACTIVATION 8 0.0210
17 SECONDARY HYPERTENSION 6 0.0210
18 VESTIBULAR MIGRAINE 5 0.0207
19 RENAL DYSPLASIA 8 0.0207
20 KOUNIS SYNDROME 42 0.0185
21 PERFUME SENSITIVITY 10 0.0176
22 GASTROINTESTINAL MUCOSA HYPERAEMIA 5 0.0169
23 CONGENITAL SKIN DIMPLES 4 0.0166
24 ANAL ATRESIA 8 0.0150
25 MASTOCYTOSIS 7 0.0148
26 CAROTID ARTERY DISSECTION 6 0.0141
27 CORONARY ARTERY DISSECTION 11 0.0128
28 SUPRAPUBIC PAIN 6 0.0118
29 MIGRAINE WITH AURA 31 0.0114
30 OCCIPITAL NEURALGIA 6 0.0106
31 PLACENTAL INSUFFICIENCY 8 0.0100
32 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 19 0.0096
33 BRAIN HYPOXIA 9 0.0089
34 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 12 0.0089
35 CLUSTER HEADACHE 12 0.0088
36 AURA 16 0.0086
37 THALAMIC INFARCTION 5 0.0084
38 TRANSIENT GLOBAL AMNESIA 6 0.0083
39 MASTOIDITIS 8 0.0082
40 GESTATIONAL HYPERTENSION 10 0.0077
41 ACQUIRED IMMUNODEFICIENCY SYNDROME 4 0.0077
42 BACTERIAL VAGINOSIS 12 0.0077
43 HYPERTENSIVE URGENCY 4 0.0072
44 CLEFT LIP AND PALATE 8 0.0072
45 MAST CELL ACTIVATION SYNDROME 10 0.0071
46 ARTERIOSPASM CORONARY 27 0.0067
47 INDUCED LABOUR 4 0.0067
48 MIGRAINE 571 0.0060
49 CLONUS 16 0.0058
50 CRANIAL NERVE DISORDER 4 0.0057
51 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 15 0.0056
52 INFUSION SITE MASS 6 0.0055
53 CRYPTORCHISM 6 0.0053
54 TONGUE COATED 9 0.0052
55 INFUSION SITE DISCHARGE 9 0.0051
56 SEROTONIN SYNDROME 98 0.0051
57 HYPERREFLEXIA 17 0.0049
58 AREFLEXIA 13 0.0049
59 HYPOSPADIAS 10 0.0048
60 OBSTRUCTIVE SLEEP APNOEA SYNDROME 7 0.0048
61 PRODUCT ADMINISTRATION INTERRUPTED 36 0.0046
62 ANTICHOLINERGIC SYNDROME 7 0.0044
63 APPLICATION SITE INFLAMMATION 6 0.0043
64 PRE-EXISTING CONDITION IMPROVED 26 0.0042
65 COMPLEX REGIONAL PAIN SYNDROME 6 0.0041
66 DEVICE INFUSION ISSUE 10 0.0040
67 RUBBER SENSITIVITY 6 0.0039
68 ANTIPSYCHOTIC DRUG LEVEL INCREASED 11 0.0039
69 INFUSION SITE IRRITATION 5 0.0039
70 FOOD INTOLERANCE 14 0.0038
71 PARADOXICAL DRUG REACTION 14 0.0038
72 OESOPHAGEAL SPASM 7 0.0038
73 GASTROINTESTINAL INJURY 10 0.0037
74 CREPITATIONS 11 0.0037
75 AGORAPHOBIA 5 0.0037
76 INFUSION SITE RASH 5 0.0036
77 OESOPHAGEAL DISORDER 14 0.0036
78 CALCINOSIS 8 0.0036
79 CATAPLEXY 5 0.0035
80 IMPAIRED GASTRIC EMPTYING 48 0.0035
81 SLEEP PARALYSIS 5 0.0034
82 MYASTHENIA GRAVIS CRISIS 5 0.0034
83 CRANIOCEREBRAL INJURY 10 0.0033
84 INFUSION SITE PRURITUS 10 0.0032
85 IMPAIRED QUALITY OF LIFE 45 0.0031
86 SHOULDER FRACTURE 5 0.0031
87 INFUSION SITE SWELLING 19 0.0030
88 EMOTIONAL POVERTY 5 0.0029
89 AUDITORY DISORDER 4 0.0028
90 COLITIS ISCHAEMIC 19 0.0028
91 TENSION HEADACHE 12 0.0028
92 SWOLLEN TONGUE 87 0.0028
93 INFUSION SITE BRUISING 6 0.0028
94 ANGLE CLOSURE GLAUCOMA 7 0.0027
95 ABNORMAL UTERINE BLEEDING 7 0.0027
96 PRODUCT PACKAGING DIFFICULT TO OPEN 7 0.0027
97 ATYPICAL PNEUMONIA 8 0.0027
98 MATERNAL EXPOSURE TIMING UNSPECIFIED 10 0.0027
99 CHRONIC GASTRITIS 6 0.0027
100 INCORRECT DRUG ADMINISTRATION RATE 11 0.0026
101 ANKYLOSING SPONDYLITIS 34 0.0026
102 POST-TRAUMATIC STRESS DISORDER 17 0.0025
103 COLITIS MICROSCOPIC 12 0.0025
104 MATERNAL EXPOSURE DURING BREAST FEEDING 10 0.0025
105 ANAL ABSCESS 13 0.0024
106 THERAPEUTIC REACTION TIME DECREASED 7 0.0024
107 CERVICAL SPINAL STENOSIS 4 0.0023
108 EMERGENCY CARE 7 0.0023
109 ANIMAL BITE 6 0.0022
110 HOMICIDAL IDEATION 9 0.0022
111 CONCUSSION 17 0.0022
112 EOSINOPHILIC OESOPHAGITIS 6 0.0022
113 MENOPAUSAL SYMPTOMS 5 0.0021
114 SINUS PAIN 5 0.0021
115 BLADDER SPASM 4 0.0021
116 RESPIRATORY SYMPTOM 6 0.0021
117 ADRENAL DISORDER 4 0.0021
118 VISUAL FIELD DEFECT 15 0.0021
119 EPIGASTRIC DISCOMFORT 8 0.0020
120 EYE MOVEMENT DISORDER 14 0.0020
121 MULTIPLE ALLERGIES 16 0.0020
122 LIGAMENT RUPTURE 9 0.0020
123 PNEUMONIA FUNGAL 8 0.0020
124 DEVICE RELATED SEPSIS 4 0.0020
125 THERAPEUTIC PRODUCT EFFECT DELAYED 9 0.0020
126 EYELID PAIN 4 0.0020
127 BLOOD PRESSURE DIASTOLIC ABNORMAL 5 0.0020
128 MENOPAUSE 5 0.0019
129 INFUSION SITE PAIN 25 0.0019
130 APLASTIC ANAEMIA 10 0.0019
131 CHRONIC SINUSITIS 7 0.0019
132 TOOTH INJURY 8 0.0018
133 GASTRIC BYPASS 4 0.0018
134 LYMPHOCYTE COUNT INCREASED 6 0.0018
135 ANGIOEDEMA 81 0.0018
136 INFECTION SUSCEPTIBILITY INCREASED 4 0.0018
137 FOOT OPERATION 9 0.0018
138 LYME DISEASE 6 0.0018
139 APNOEA 14 0.0018
140 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 98 0.0018
141 INFUSION SITE ERYTHEMA 15 0.0018
142 BLOOD PRESSURE DIASTOLIC INCREASED 8 0.0017
143 POST PROCEDURAL INFECTION 14 0.0017
144 DEPRESSIVE SYMPTOM 6 0.0017
145 MACULOPATHY 6 0.0017
146 LIVE BIRTH 14 0.0017
147 DERMATITIS CONTACT 19 0.0017
148 DYSPHONIA 97 0.0017
149 MUSCLE FATIGUE 7 0.0017
150 ESCHERICHIA URINARY TRACT INFECTION 7 0.0016
151 PHARYNGEAL SWELLING 16 0.0016
152 SWELLING FACE 106 0.0016
153 BLOOD IMMUNOGLOBULIN G DECREASED 4 0.0016
154 SMALL FOR DATES BABY 8 0.0016
155 TONGUE DISCOLOURATION 7 0.0016
156 HYPERPARATHYROIDISM SECONDARY 4 0.0016
157 SNORING 6 0.0016
158 PARANASAL SINUS DISCOMFORT 6 0.0016
159 HEREDITARY ANGIOEDEMA 17 0.0016
160 EUPHORIC MOOD 16 0.0016
161 PORTAL VEIN THROMBOSIS 5 0.0015
162 SOMNAMBULISM 10 0.0015
163 DEAFNESS NEUROSENSORY 5 0.0015
164 OTITIS MEDIA 5 0.0015
165 CORONAVIRUS INFECTION 10 0.0015
166 BODY HEIGHT DECREASED 16 0.0015
167 BRAIN INJURY 15 0.0015
168 SUSPECTED SUICIDE 7 0.0015
169 ENURESIS 6 0.0015
170 FEELING DRUNK 11 0.0015
171 VIRAL UPPER RESPIRATORY TRACT INFECTION 7 0.0015
172 HYDRONEPHROSIS 11 0.0015
173 MENISCUS INJURY 9 0.0015
174 HYPERAESTHESIA 12 0.0015
175 INTESTINAL ISCHAEMIA 8 0.0015
176 INFUSION SITE EXTRAVASATION 9 0.0014
177 INSURANCE ISSUE 22 0.0014
178 INTRACRANIAL PRESSURE INCREASED 8 0.0014
179 SKIN INFECTION 16 0.0014
180 HANGOVER 5 0.0014
181 CANDIDA INFECTION 24 0.0014
182 SEASONAL ALLERGY 20 0.0014
183 INJECTION SITE INFLAMMATION 7 0.0014
184 IMPAIRED WORK ABILITY 30 0.0014
185 GALACTORRHOEA 9 0.0014
186 ANURIA 12 0.0014
187 MIDDLE INSOMNIA 26 0.0014
188 FIBULA FRACTURE 4 0.0014
189 EYELID PTOSIS 14 0.0014
190 GASTROINTESTINAL NECROSIS 4 0.0014
191 DRUG INTOLERANCE 132 0.0014
192 SLEEP APNOEA SYNDROME 26 0.0014
193 WHEELCHAIR USER 6 0.0013
194 PRODUCT TASTE ABNORMAL 18 0.0013
195 PAROSMIA 10 0.0013
196 FACE INJURY 5 0.0013
197 GAIT INABILITY 44 0.0013
198 FOETAL GROWTH RESTRICTION 8 0.0013
199 BLADDER DISORDER 13 0.0013
200 HYPOKINESIA 19 0.0013
201 NECK PAIN 73 0.0013
202 OVARIAN CYST 13 0.0013
203 HEAD DISCOMFORT 23 0.0013
204 SEDATION 34 0.0013
205 NEPHROGENIC ANAEMIA 6 0.0013
206 APHTHOUS ULCER 10 0.0013
207 FEELING OF DESPAIR 6 0.0013
208 SPINAL PAIN 15 0.0013
209 ORAL INFECTION 5 0.0013
210 ASTHENOPIA 7 0.0013
211 INITIAL INSOMNIA 13 0.0013
212 ENDOMETRIOSIS 6 0.0013
213 ACCIDENT 15 0.0013
214 VERTIGO 76 0.0012
215 TRIGEMINAL NEURALGIA 5 0.0012
216 THERAPEUTIC RESPONSE SHORTENED 41 0.0012
217 PERONEAL NERVE PALSY 7 0.0012
218 INCORRECT DISPOSAL OF PRODUCT 4 0.0012
219 PHOTOPHOBIA 23 0.0012
220 BRAIN FOG 19 0.0012
221 SPINAL STENOSIS 5 0.0012
222 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 4 0.0012
223 ANXIETY DISORDER 4 0.0012
224 SELF-INJURIOUS IDEATION 5 0.0012
225 TENDON PAIN 9 0.0012
226 ATTENTION DEFICIT HYPERACTIVITY DISORDER 5 0.0012
227 GASTROINTESTINAL PAIN 13 0.0012
228 TOOTH ABSCESS 12 0.0012
229 ANAPHYLACTIC REACTION 65 0.0012
230 PETIT MAL EPILEPSY 6 0.0012
231 SINUSITIS 120 0.0012
232 ROTATOR CUFF SYNDROME 15 0.0012
233 HEPATIC FIBROSIS 4 0.0012
234 FUNCTIONAL GASTROINTESTINAL DISORDER 4 0.0012
235 HYPOPNOEA 4 0.0012
236 ANGINA PECTORIS 33 0.0012
237 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
238 DIVERTICULUM INTESTINAL 5 0.0011
239 ONYCHOMYCOSIS 5 0.0011
240 RHINITIS ALLERGIC 5 0.0011
241 FOOD POISONING 6 0.0011
242 RHINITIS 9 0.0011
243 SWELLING OF EYELID 7 0.0011
244 BRUXISM 6 0.0011
245 STRESS FRACTURE 6 0.0011
246 FIBROMYALGIA 27 0.0011
247 SURGERY 65 0.0011
248 HIP SURGERY 6 0.0011
249 NORMAL NEWBORN 6 0.0011
250 VASCULAR DEVICE INFECTION 5 0.0011
251 RESTLESS LEGS SYNDROME 20 0.0011
252 FOREIGN BODY SENSATION IN EYES 7 0.0011
253 HAEMOGLOBIN INCREASED 5 0.0011
254 ABDOMINAL HERNIA 5 0.0011
255 BLOOD IRON DECREASED 13 0.0011
256 INTERVERTEBRAL DISC DEGENERATION 10 0.0011
257 CHRONIC KIDNEY DISEASE 82 0.0011
258 DISABILITY 21 0.0011
259 SKIN ABRASION 5 0.0011
260 EAR INFECTION 28 0.0011
261 WEIGHT FLUCTUATION 11 0.0011
262 TREATMENT FAILURE 87 0.0010
263 HEADACHE 658 0.0010
264 DISSOCIATION 8 0.0010
265 INJECTION SITE RASH 32 0.0010
266 JOINT DISLOCATION 11 0.0010
267 MOUTH SWELLING 6 0.0010
268 UPPER RESPIRATORY TRACT INFECTION 48 0.0010
269 THROAT TIGHTNESS 28 0.0010
270 SKIN WARM 6 0.0010
271 APHASIA 31 0.0010
272 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 73 0.0010
273 SNEEZING 23 0.0010
274 SPINAL OSTEOARTHRITIS 9 0.0010
275 APPLICATION SITE BURN 5 0.0010
276 MUCOUS STOOLS 5 0.0010
277 NASAL DISCOMFORT 8 0.0010
278 FACIAL PAIN 9 0.0010
279 INTERVERTEBRAL DISC PROTRUSION 22 0.0010
280 FOOT FRACTURE 19 0.0010
281 LIMB DISCOMFORT 31 0.0010
282 ANAL INCONTINENCE 9 0.0010
283 BURSITIS 12 0.0010
284 NOCTURIA 12 0.0010
285 APPLICATION SITE DISCOLOURATION 4 0.0010
286 ORAL PAIN 22 0.0010
287 NEPHROLITHIASIS 45 0.0010
288 IRRITABLE BOWEL SYNDROME 21 0.0010
289 PHLEBITIS 5 0.0010
290 SPINAL OPERATION 12 0.0010
291 PRODUCT SUBSTITUTION ISSUE 56 0.0010
292 OLIGURIA 6 0.0010
293 POOR VENOUS ACCESS 10 0.0010
294 PSORIATIC ARTHROPATHY 39 0.0010
295 MALABSORPTION 5 0.0010
296 CHEST DISCOMFORT 97 0.0009
297 INTENTIONAL DOSE OMISSION 27 0.0009
298 ARTHROPOD BITE 7 0.0009
299 ABSCESS LIMB 4 0.0009
300 INJECTION SITE PRURITUS 62 0.0009
301 VITAMIN D DEFICIENCY 9 0.0009
302 KIDNEY INFECTION 18 0.0009
303 SINUS DISORDER 18 0.0009
304 PRODUCT COMMUNICATION ISSUE 8 0.0009
305 NEURALGIA 22 0.0009
306 ANKLE FRACTURE 14 0.0009
307 BLOOD CREATINE INCREASED 4 0.0009
308 HALLUCINATION, VISUAL 19 0.0009
309 MENINGITIS 6 0.0009
310 INJECTION SITE URTICARIA 22 0.0009
311 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 43 0.0009
312 INTERMENSTRUAL BLEEDING 5 0.0009
313 PRODUCT LEAKAGE 5 0.0009
314 HEAVY MENSTRUAL BLEEDING 8 0.0009
315 GASTROENTERITIS VIRAL 16 0.0009
316 OROPHARYNGEAL PAIN 82 0.0009
317 ACUTE RESPIRATORY FAILURE 17 0.0009
318 PRODUCT DOSE OMISSION IN ERROR 25 0.0009
319 POOR QUALITY SLEEP 19 0.0009
320 INJECTION SITE DISCOLOURATION 11 0.0009
321 PANIC ATTACK 32 0.0009
322 COVID-19 154 0.0009
323 HYPOTHYROIDISM 28 0.0009
324 INJECTION SITE WARMTH 18 0.0009
325 ILLNESS 90 0.0009
326 OBSESSIVE-COMPULSIVE DISORDER 7 0.0009
327 HYPERSENSITIVITY 161 0.0009
328 MUSCLE TIGHTNESS 14 0.0009
329 HYPERVENTILATION 5 0.0009
330 MULTIPLE SCLEROSIS RELAPSE 59 0.0009
331 DERMATITIS ATOPIC 45 0.0009
332 COLD SWEAT 15 0.0009
333 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
334 CLOSTRIDIUM DIFFICILE COLITIS 9 0.0008
335 ACUTE MYOCARDIAL INFARCTION 25 0.0008
336 THERAPEUTIC RESPONSE UNEXPECTED 38 0.0008
337 THROAT IRRITATION 38 0.0008
338 GASTRIC ULCER 16 0.0008
339 GESTATIONAL DIABETES 4 0.0008
340 TOOTH INFECTION 11 0.0008
341 WRIST FRACTURE 10 0.0008
342 SKIN LACERATION 9 0.0008
343 INJECTION SITE VESICLES 5 0.0008
344 FAECES SOFT 6 0.0008
345 CLOSTRIDIUM DIFFICILE INFECTION 18 0.0008
346 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 14 0.0008
347 BRONCHITIS 61 0.0008
348 INGUINAL HERNIA 5 0.0008
349 FACIAL PARALYSIS 7 0.0008
350 HAEMORRHOIDAL HAEMORRHAGE 4 0.0008
351 VITAMIN D DECREASED 7 0.0008
352 NASAL CONGESTION 48 0.0008
353 TOOTH FRACTURE 9 0.0008
354 RESPIRATORY DEPRESSION 10 0.0008
355 SINUS CONGESTION 11 0.0008
356 PAIN IN JAW 23 0.0008
357 NERVE INJURY 9 0.0008
358 LIGAMENT SPRAIN 8 0.0008
359 CARDIAC MURMUR 7 0.0008
360 HYSTERECTOMY 7 0.0008
361 EMBEDDED DEVICE 8 0.0008
362 DUODENAL ULCER PERFORATION 6 0.0008
363 RESPIRATORY TRACT INFECTION 21 0.0008
364 IMMUNODEFICIENCY 12 0.0008
365 RESPIRATORY SYNCYTIAL VIRUS INFECTION 7 0.0008
366 EPSTEIN-BARR VIRUS INFECTION 5 0.0008
367 INJECTION SITE SWELLING 61 0.0008
368 GASTROOESOPHAGEAL REFLUX DISEASE 64 0.0008
369 PRODUCT PHYSICAL ISSUE 16 0.0008
370 DYSPEPSIA 78 0.0008
371 DYSPHORIA 4 0.0008
372 CHOLECYSTECTOMY 9 0.0008
373 DISCOMFORT 48 0.0008
374 NAUSEA 619 0.0008
375 GASTROINTESTINAL INFECTION 7 0.0008
376 FOOD ALLERGY 6 0.0008
377 LIMB INJURY 21 0.0008
378 HYPERPROLACTINAEMIA 5 0.0008
379 DIPLOPIA 20 0.0008
380 ORAL HERPES 15 0.0008
381 SEXUAL DYSFUNCTION 9 0.0008
382 MEMORY IMPAIRMENT 105 0.0008
383 POLYP 5 0.0008
384 PRODUCT USE IN UNAPPROVED INDICATION 189 0.0008
385 PARAESTHESIA ORAL 11 0.0008
386 EYE PAIN 43 0.0008
387 PRODUCT DOSE OMISSION ISSUE 224 0.0008
388 ABNORMAL DREAMS 21 0.0008
389 ORAL CANDIDIASIS 10 0.0008
390 OVARIAN CANCER 7 0.0008
391 WALKING AID USER 5 0.0008
392 SARS-COV-2 TEST POSITIVE 10 0.0008
393 INCONTINENCE 8 0.0008
394 THERAPY NON-RESPONDER 34 0.0008
395 SENSORY DISTURBANCE 12 0.0007
396 ANAL FISSURE 4 0.0007
397 SENSORY LOSS 6 0.0007
398 LOSS OF CONSCIOUSNESS 95 0.0007
399 POSTOPERATIVE WOUND INFECTION 5 0.0007
400 PHARYNGITIS STREPTOCOCCAL 8 0.0007
401 BACK INJURY 8 0.0007
402 THIRST 13 0.0007
403 RESPIRATION ABNORMAL 5 0.0007
404 SYNOVITIS 13 0.0007
405 HYPERTENSIVE CRISIS 8 0.0007
406 TINNITUS 33 0.0007
407 FLUSHING 73 0.0007
408 HEART RATE ABNORMAL 4 0.0007
409 DRUG USE DISORDER 6 0.0007
410 SENSATION OF FOREIGN BODY 6 0.0007
411 HYPOAESTHESIA 106 0.0007
412 HAND FRACTURE 5 0.0007
413 INJECTION SITE MASS 26 0.0007
414 ANXIETY 200 0.0007
415 DRY EYE 35 0.0007
416 SCAR 12 0.0007
417 NEUTROPENIC SEPSIS 5 0.0007
418 DEPRESSION 159 0.0007
419 PARALYSIS 10 0.0007
420 CONSTIPATION 152 0.0007
421 CHEST PAIN 129 0.0007
422 HIATUS HERNIA 9 0.0007
423 INJECTION SITE INDURATION 9 0.0007
424 SKIN SWELLING 6 0.0007
425 PRODUCTIVE COUGH 33 0.0007
426 FUNGAL INFECTION 23 0.0007
427 SPEECH DISORDER 36 0.0007
428 PARAESTHESIA 108 0.0007
429 VOMITING 322 0.0007
430 PALPITATIONS 80 0.0007
431 NIGHT SWEATS 22 0.0007
432 EAR DISCOMFORT 7 0.0007
433 INJECTION SITE BRUISING 54 0.0007
434 FOETAL EXPOSURE DURING PREGNANCY 55 0.0007
435 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
436 TOOTH DISORDER 15 0.0007
437 ATAXIA 8 0.0007
438 PRODUCT DOSE OMISSION 44 0.0007
439 CHOLECYSTITIS 8 0.0007
440 FOREIGN BODY IN REPRODUCTIVE TRACT 6 0.0007
441 TREMOR 111 0.0007
442 PRODUCT ODOUR ABNORMAL 7 0.0007
443 CHOKING 13 0.0007
444 OROPHARYNGEAL DISCOMFORT 6 0.0007
445 PRESYNCOPE 16 0.0007
446 ASTHMA 74 0.0007
447 APPLICATION SITE RASH 9 0.0007
448 DRY MOUTH 53 0.0007
449 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
450 MUSCLE TWITCHING 15 0.0007
451 NERVE COMPRESSION 6 0.0006
452 IRON DEFICIENCY ANAEMIA 6 0.0006
453 BACK PAIN 151 0.0006
454 THERAPEUTIC PRODUCT EFFECT DECREASED 29 0.0006
455 PRODUCT DISTRIBUTION ISSUE 6 0.0006
456 HUNGER 9 0.0006
457 CYST 8 0.0006
458 ARTHRALGIA 268 0.0006
459 EXTRAPYRAMIDAL DISORDER 16 0.0006
460 LABORATORY TEST ABNORMAL 19 0.0006
461 EYE IRRITATION 37 0.0006
462 CARPAL TUNNEL SYNDROME 9 0.0006
463 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11 0.0006
464 THERAPY PARTIAL RESPONDER 10 0.0006
465 INTENTIONAL PRODUCT USE ISSUE 56 0.0006
466 GASTROINTESTINAL INFLAMMATION 5 0.0006
467 HEART RATE INCREASED 63 0.0006
468 SOMNOLENCE 128 0.0006
469 SPUTUM DISCOLOURED 6 0.0006
470 OSTEOPOROSIS 26 0.0006
471 PRODUCT PRESCRIBING ERROR 15 0.0006
472 HYPERSOMNIA 18 0.0006
473 MALNUTRITION 7 0.0006
474 ENTERITIS 4 0.0006
475 LOWER LIMB FRACTURE 12 0.0006
476 DIZZINESS 311 0.0006
477 OCULAR DISCOMFORT 7 0.0006
478 MOVEMENT DISORDER 20 0.0006
479 ABDOMINAL DISTENSION 65 0.0006
480 FISTULA 7 0.0006
481 SUICIDAL IDEATION 57 0.0006
482 BLOOD PRESSURE INCREASED 95 0.0006
483 CARDIAC FLUTTER 4 0.0006
484 EAR PAIN 12 0.0006
485 ISCHAEMIC STROKE 11 0.0006
486 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 111 0.0006
487 THROMBOTIC MICROANGIOPATHY 6 0.0006
488 AUTOIMMUNE DISORDER 6 0.0006
489 DECUBITUS ULCER 5 0.0006
490 INFLAMMATORY BOWEL DISEASE 6 0.0006
491 INTESTINAL OBSTRUCTION 23 0.0006
492 KNEE OPERATION 6 0.0006
493 SLEEP DISORDER 43 0.0006
494 INJECTION SITE PAIN 186 0.0006
495 SOPOR 8 0.0006
496 MENSTRUAL DISORDER 5 0.0006
497 BALANCE DISORDER 52 0.0006
498 BLOOD POTASSIUM DECREASED 18 0.0006
499 QUALITY OF LIFE DECREASED 8 0.0006
500 LACRIMATION INCREASED 18 0.0006
501 DISTURBANCE IN ATTENTION 32 0.0006
502 OSTEOPENIA 9 0.0006
503 DYSPHAGIA 56 0.0006
504 SLUGGISHNESS 6 0.0006
505 SWELLING 55 0.0006
506 INFECTION 85 0.0006
507 BLOOD PRESSURE DECREASED 39 0.0006
508 DEPRESSED MOOD 31 0.0006
509 INJECTION SITE REACTION 40 0.0006
510 TENDONITIS 9 0.0006
511 PSYCHOLOGICAL TRAUMA 5 0.0006
512 IMPAIRED HEALING 19 0.0006
513 MUSCLE STRAIN 5 0.0006
514 HAIR GROWTH ABNORMAL 4 0.0006
515 TENDERNESS 6 0.0006
516 DEVICE DIFFICULT TO USE 38 0.0006
517 RESTLESSNESS 21 0.0006
518 DEAFNESS 15 0.0006
519 LETHARGY 33 0.0006
520 MASS 8 0.0006
521 INCORRECT DOSE ADMINISTERED BY DEVICE 15 0.0006
522 PRODUCT USE COMPLAINT 9 0.0006
523 ANHEDONIA 15 0.0006
524 HOT FLUSH 43 0.0006
525 MUSCLE SPASTICITY 7 0.0006
526 DRUG INEFFECTIVE 749 0.0006
527 BLINDNESS UNILATERAL 8 0.0006
528 RESPIRATORY TRACT CONGESTION 9 0.0006
529 FATIGUE 441 0.0006
530 WEIGHT DECREASED 158 0.0006
531 LYMPHOCYTE COUNT DECREASED 10 0.0006
532 EYE PRURITUS 19 0.0006
533 INJECTION SITE ERYTHEMA 70 0.0006
534 ABDOMINAL PAIN 131 0.0006
535 RETCHING 12 0.0006
536 BREAST PAIN 6 0.0006
537 PAIN 345 0.0006
538 MATERNAL EXPOSURE DURING PREGNANCY 50 0.0006
539 FEAR OF INJECTION 4 0.0006
540 INSOMNIA 149 0.0006
541 DYSARTHRIA 21 0.0006
542 DEPRESSED LEVEL OF CONSCIOUSNESS 22 0.0006
543 ACCIDENTAL UNDERDOSE 8 0.0006
544 BLOOD PRESSURE ABNORMAL 11 0.0006
545 TOOTHACHE 10 0.0006
546 PULMONARY THROMBOSIS 6 0.0005
547 COUGH 154 0.0005
548 HIDRADENITIS 5 0.0005
549 GASTROENTERITIS 8 0.0005
550 EXOSTOSIS 5 0.0005
551 MYDRIASIS 7 0.0005
552 MULTIPLE SCLEROSIS 26 0.0005
553 HYPERTENSION 115 0.0005
554 CEREBRAL DISORDER 4 0.0005
555 PROCEDURAL PAIN 15 0.0005
556 URINARY INCONTINENCE 16 0.0005
557 MUSCLE SPASMS 99 0.0005
558 HEPATIC STEATOSIS 10 0.0005
559 RIB FRACTURE 11 0.0005
560 URINARY TRACT INFECTION 91 0.0005
561 FLANK PAIN 5 0.0005
562 NASOPHARYNGITIS 98 0.0005
563 EYE INFECTION 6 0.0005
564 SQUAMOUS CELL CARCINOMA 5 0.0005
565 AGITATION 39 0.0005
566 EXPOSURE DURING PREGNANCY 33 0.0005
567 ALOPECIA 104 0.0005
568 INFLUENZA 59 0.0005
569 TACHYCARDIA 47 0.0005
570 THERAPY CESSATION 27 0.0005
571 ABDOMINAL DISCOMFORT 88 0.0005
572 INCREASED APPETITE 10 0.0005
573 CONDITION AGGRAVATED 159 0.0005
574 BOWEL MOVEMENT IRREGULARITY 4 0.0005
575 FEELING HOT 32 0.0005
576 FEELING ABNORMAL 125 0.0005
577 UNDERDOSE 38 0.0005
578 PAIN OF SKIN 14 0.0005
579 PERIPHERAL SWELLING 80 0.0005
580 HERNIA 10 0.0005
581 MUSCULOSKELETAL CHEST PAIN 8 0.0005
582 BLISTER 29 0.0005
583 UNEVALUABLE EVENT 39 0.0005
584 NEEDLE ISSUE 15 0.0005
585 JOINT INJURY 11 0.0005
586 ABDOMINAL PAIN UPPER 106 0.0005
587 MUSCULOSKELETAL STIFFNESS 45 0.0005
588 WEIGHT INCREASED 115 0.0005
589 HAEMATEMESIS 13 0.0005
590 HAEMORRHAGIC STROKE 4 0.0005
591 SKIN FISSURES 10 0.0005
592 SEIZURE 59 0.0005
593 RHINORRHOEA 33 0.0005
594 INFLUENZA LIKE ILLNESS 42 0.0005
595 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
596 RENAL TUBULAR NECROSIS 5 0.0005
597 AFFECTIVE DISORDER 4 0.0005
598 URTICARIA 85 0.0005
599 SYSTEMIC LUPUS ERYTHEMATOSUS 18 0.0005
600 THERAPY INTERRUPTED 36 0.0005
601 HALLUCINATION, AUDITORY 8 0.0005
602 FEELING COLD 14 0.0005
603 ULCER 8 0.0005
604 GINGIVAL PAIN 4 0.0005
605 GASTROINTESTINAL DISORDER 45 0.0005
606 MOOD SWINGS 16 0.0005
607 UPPER LIMB FRACTURE 10 0.0005
608 RESPIRATORY DISORDER 15 0.0005
609 ABORTION SPONTANEOUS 20 0.0005
610 FRUSTRATION TOLERANCE DECREASED 4 0.0005
611 MENTAL IMPAIRMENT 12 0.0005
612 PRODUCT ADMINISTRATION ERROR 10 0.0005
613 BACK DISORDER 8 0.0005
614 NIGHTMARE 17 0.0005
615 JOINT SWELLING 59 0.0005
616 HELICOBACTER INFECTION 5 0.0005
617 STAPHYLOCOCCAL INFECTION 16 0.0005
618 OCULAR HYPERAEMIA 23 0.0005
619 DYSGEUSIA 36 0.0005
620 HYPERTHYROIDISM 7 0.0005
621 THINKING ABNORMAL 9 0.0005
622 ILEUS 6 0.0005
623 IRRITABILITY 29 0.0005
624 HEMIPLEGIA 4 0.0005
625 VIRAL INFECTION 16 0.0005
626 TUBULOINTERSTITIAL NEPHRITIS 9 0.0005
627 SKIN DISORDER 16 0.0005
628 ECZEMA 25 0.0005
629 FALL 159 0.0005
630 BLOOD SODIUM DECREASED 9 0.0005
631 AMNESIA 31 0.0005
632 INJECTION SITE DISCOMFORT 5 0.0005
633 BLOOD URINE PRESENT 9 0.0005
634 MUSCULOSKELETAL DISORDER 9 0.0005
635 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
636 FEELING JITTERY 9 0.0005
637 BURNING SENSATION 33 0.0005
638 ARTHRITIS 37 0.0005
639 CHILLS 55 0.0005
640 ADVERSE DRUG REACTION 42 0.0005
641 CONTUSION 45 0.0005
642 DYSTONIA 9 0.0005
643 ACUTE KIDNEY INJURY 71 0.0005
644 BLOOD MAGNESIUM DECREASED 4 0.0005
645 DECREASED ACTIVITY 5 0.0005
646 MENSTRUATION DELAYED 5 0.0005
647 BIPOLAR DISORDER 5 0.0005
648 VISION BLURRED 63 0.0005
649 RASH MACULAR 16 0.0005
650 BEDRIDDEN 6 0.0005
651 BLOOD CALCIUM INCREASED 4 0.0005
652 POLLAKIURIA 19 0.0005
653 GROIN PAIN 4 0.0005
654 IMMUNE SYSTEM DISORDER 6 0.0005
655 DEVICE RELATED INFECTION 7 0.0005
656 OFF LABEL USE 398 0.0005
657 INFUSION RELATED REACTION 30 0.0005
658 ADVERSE REACTION 6 0.0005
659 DECREASED APPETITE 105 0.0005
660 INJECTION SITE HAEMORRHAGE 36 0.0005
661 PREGNANCY 9 0.0004
662 DIARRHOEA 290 0.0004
663 COLITIS ULCERATIVE 20 0.0004
664 DRUG DOSE OMISSION BY DEVICE 35 0.0004
665 MOBILITY DECREASED 32 0.0004
666 STOMATITIS 27 0.0004
667 PRURITUS 171 0.0004
668 ELECTROCARDIOGRAM QT PROLONGED 16 0.0004
669 BLOOD CALCIUM DECREASED 5 0.0004
670 PAIN IN EXTREMITY 131 0.0004
671 ANGER 15 0.0004
672 COMPLICATION OF DEVICE REMOVAL 8 0.0004
673 HEAD INJURY 14 0.0004
674 BODY TEMPERATURE INCREASED 9 0.0004
675 PELVIC PAIN 8 0.0004
676 MALAISE 193 0.0004
677 MUSCULAR WEAKNESS 50 0.0004
678 WHEEZING 26 0.0004
679 SCAB 5 0.0004
680 PERIPHERAL COLDNESS 6 0.0004
681 CENTRAL NERVOUS SYSTEM LESION 6 0.0004
682 VISUAL IMPAIRMENT 54 0.0004
683 MYALGIA 74 0.0004
684 NEOPLASM 5 0.0004
685 INCREASED TENDENCY TO BRUISE 4 0.0004
686 ORAL DISCOMFORT 6 0.0004
687 EYE SWELLING 16 0.0004
688 DERMATITIS 9 0.0004
689 DEHYDRATION 57 0.0004
690 MOUTH ULCERATION 9 0.0004
691 OSTEOARTHRITIS 18 0.0004
692 LYMPHADENOPATHY 15 0.0004
693 COVID-19 PNEUMONIA 5 0.0004
694 DRUG LEVEL INCREASED 7 0.0004
695 EATING DISORDER 9 0.0004
696 NERVOUSNESS 22 0.0004
697 SYNCOPE 42 0.0004
698 APPLICATION SITE ERYTHEMA 11 0.0004
699 JOINT STIFFNESS 11 0.0004
700 HERPES ZOSTER 24 0.0004
701 PRURITUS GENERALISED 9 0.0004
702 AFFECT LABILITY 4 0.0004
703 GLAUCOMA 8 0.0004
704 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
705 CRYING 15 0.0004
706 THERAPEUTIC RESPONSE DECREASED 25 0.0004
707 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
708 HAEMORRHOIDS 8 0.0004
709 NEUROPATHY PERIPHERAL 39 0.0004
710 APPLICATION SITE PAIN 9 0.0004
711 CYSTITIS 13 0.0004
712 DYSPNOEA 231 0.0004
713 BLOOD CHOLESTEROL INCREASED 19 0.0004
714 ACCIDENTAL EXPOSURE TO PRODUCT 42 0.0004
715 FREQUENT BOWEL MOVEMENTS 11 0.0004
716 COGNITIVE DISORDER 19 0.0004
717 FLATULENCE 23 0.0004
718 TENDON RUPTURE 5 0.0004
719 PRODUCT USE ISSUE 76 0.0004
720 HYPERHIDROSIS 52 0.0004
721 APPLICATION SITE IRRITATION 5 0.0004
722 AGEUSIA 10 0.0004
723 SECRETION DISCHARGE 5 0.0004
724 HYPOAESTHESIA ORAL 6 0.0004
725 CELLULITIS 20 0.0004
726 EMPHYSEMA 4 0.0004
727 CHOLELITHIASIS 13 0.0004
728 COLITIS 15 0.0004
729 FEEDING DISORDER 8 0.0004
730 DRY THROAT 4 0.0004
731 BONE PAIN 23 0.0004
732 HYPOGLYCAEMIA 19 0.0004
733 HYPOPHAGIA 10 0.0004
734 PSORIASIS 51 0.0004
735 PHARYNGEAL OEDEMA 6 0.0004
736 INFLAMMATION 20 0.0004
737 RASH PRURITIC 21 0.0004
738 OSTEOMYELITIS 7 0.0004
739 EYE DISCHARGE 4 0.0004
740 C-REACTIVE PROTEIN INCREASED 14 0.0004
741 BASAL CELL CARCINOMA 6 0.0004
742 NODULE 5 0.0004
743 ROAD TRAFFIC ACCIDENT 16 0.0004
744 MUCOSAL INFLAMMATION 10 0.0004
745 PULMONARY CONGESTION 5 0.0004
746 GASTRIC DISORDER 13 0.0004
747 ARTHROPATHY 21 0.0004
748 ASTHENIA 142 0.0004
749 CONJUNCTIVITIS 7 0.0004
750 DYSMENORRHOEA 5 0.0004
751 DYSSTASIA 11 0.0004
752 GAIT DISTURBANCE 72 0.0004
753 EPISTAXIS 28 0.0004
754 MENSTRUATION IRREGULAR 10 0.0004
755 COMPLETED SUICIDE 31 0.0004
756 RENAL INJURY 11 0.0004
757 HEART RATE DECREASED 13 0.0004
758 BLOOD BILIRUBIN INCREASED 10 0.0004
759 TACHYPNOEA 5 0.0004
760 PRODUCT DISPENSING ERROR 8 0.0004
761 DRY SKIN 49 0.0004
762 MOOD ALTERED 10 0.0004
763 POST PROCEDURAL COMPLICATION 7 0.0004
764 CONTRAINDICATED PRODUCT ADMINISTERED 11 0.0004
765 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
766 ERUCTATION 7 0.0004
767 DENTAL CARIES 4 0.0004
768 LIP SWELLING 12 0.0004
769 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 73 0.0004
770 STEVENS-JOHNSON SYNDROME 8 0.0004
771 COORDINATION ABNORMAL 5 0.0004
772 HALLUCINATION 27 0.0004
773 HOSPITALISATION 55 0.0004
774 RASH PAPULAR 8 0.0004
775 EMOTIONAL DISORDER 11 0.0004
776 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
777 PANCREATITIS ACUTE 8 0.0004
778 OXYGEN SATURATION DECREASED 20 0.0004
779 SKIN REACTION 5 0.0004
780 DIABETES MELLITUS 27 0.0004
781 HEMIPARESIS 6 0.0004
782 FLUID RETENTION 18 0.0004
783 LYMPHOPENIA 5 0.0004
784 COMPLICATION OF DEVICE INSERTION 7 0.0004
785 SKIN IRRITATION 16 0.0003
786 MUSCULOSKELETAL DISCOMFORT 6 0.0003
787 EXPOSURE VIA SKIN CONTACT 9 0.0003
788 DRUG INTERACTION 55 0.0003
789 SUICIDE ATTEMPT 21 0.0003
790 DYSPNOEA EXERTIONAL 13 0.0003
791 RASH 150 0.0003
792 AMENORRHOEA 6 0.0003
793 RENAL FAILURE 45 0.0003
794 MYOCARDIAL INFARCTION 59 0.0003
795 TOOTH LOSS 7 0.0003
796 SKIN HAEMORRHAGE 5 0.0003
797 SKIN BURNING SENSATION 24 0.0003
798 WITHDRAWAL SYNDROME 14 0.0003
799 ADRENAL INSUFFICIENCY 4 0.0003
800 BONE DISORDER 6 0.0003
801 EPILEPSY 10 0.0003
802 PYREXIA 113 0.0003
803 MUSCULOSKELETAL PAIN 17 0.0003
804 ABNORMAL WEIGHT GAIN 4 0.0003
805 DEEP VEIN THROMBOSIS 21 0.0003
806 FAECES DISCOLOURED 7 0.0003
807 WOUND 9 0.0003
808 PANCREATITIS 17 0.0003
809 BACTERIAL INFECTION 6 0.0003
810 HAIR COLOUR CHANGES 4 0.0003
811 MENINGIOMA 5 0.0003
812 SKIN EXFOLIATION 27 0.0003
813 BLINDNESS 13 0.0003
814 RHEUMATOID ARTHRITIS 36 0.0003
815 HYPOCALCAEMIA 6 0.0003
816 PRODUCT COMPLAINT 8 0.0003
817 CONFUSIONAL STATE 51 0.0003
818 SEPSIS 35 0.0003
819 RASH ERYTHEMATOUS 15 0.0003
820 SCIATICA 5 0.0003
821 ABSCESS 5 0.0003
822 ERYTHEMA 64 0.0003
823 THROMBOSIS 25 0.0003
824 TREATMENT NONCOMPLIANCE 17 0.0003
825 APPLICATION SITE PRURITUS 7 0.0003
826 HEPATIC ENZYME INCREASED 21 0.0003
827 EMOTIONAL DISTRESS 37 0.0003
828 SKIN DISCOLOURATION 14 0.0003
829 MULTIPLE FRACTURES 5 0.0003
830 MANIA 5 0.0003
831 PHOTOSENSITIVITY REACTION 5 0.0003
832 INCORRECT DOSE ADMINISTERED 69 0.0003
833 FULL BLOOD COUNT DECREASED 6 0.0003
834 PERICARDITIS 5 0.0003
835 TASTE DISORDER 6 0.0003
836 PNEUMONIA 95 0.0003
837 PRODUCT PREPARATION ERROR 6 0.0003
838 MENTAL STATUS CHANGES 8 0.0003
839 DEVICE USE ERROR 10 0.0003
840 ORTHOSTATIC HYPOTENSION 5 0.0003
841 LOWER RESPIRATORY TRACT INFECTION 13 0.0003
842 CATARACT 17 0.0003
843 PULMONARY EMBOLISM 27 0.0003
844 BRADYCARDIA 15 0.0003
845 GALLBLADDER DISORDER 5 0.0003
846 DEVICE ISSUE 25 0.0003
847 ANOSMIA 4 0.0003
848 LEUKOCYTOSIS 5 0.0003
849 MENTAL DISORDER 12 0.0003
850 APATHY 4 0.0003
851 HYPOTENSION 55 0.0003
852 END STAGE RENAL DISEASE 5 0.0003
853 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5 0.0003
854 MELAENA 6 0.0003
855 ASCITES 8 0.0003
856 LIVER DISORDER 12 0.0003
857 GLOSSODYNIA 6 0.0003
858 GASTRITIS 7 0.0003
859 LUNG DISORDER 13 0.0003
860 PRODUCT QUALITY ISSUE 36 0.0003
861 ECONOMIC PROBLEM 4 0.0003
862 HAEMATURIA 9 0.0003
863 BREAST CANCER FEMALE 7 0.0003
864 HIP ARTHROPLASTY 4 0.0003
865 FEAR 7 0.0003
866 AGGRESSION 13 0.0003
867 GENERAL PHYSICAL HEALTH DETERIORATION 30 0.0003
868 HYPOXIA 9 0.0003
869 SKIN LESION 7 0.0003
870 MENORRHAGIA 5 0.0003
871 HAEMATOCHEZIA 14 0.0003
872 DIVERTICULITIS 7 0.0003
873 ACTIVITIES OF DAILY LIVING IMPAIRED 5 0.0003
874 PRODUCT ADHESION ISSUE 9 0.0003
875 INTENTIONAL PRODUCT MISUSE 22 0.0003
876 SPINAL FRACTURE 5 0.0002
877 WHITE BLOOD CELL COUNT DECREASED 27 0.0002
878 LOCALISED INFECTION 6 0.0002
879 CEREBROVASCULAR ACCIDENT 42 0.0002
880 DRUG EFFECT INCOMPLETE 9 0.0002
881 DEVICE BREAKAGE 10 0.0002
882 DYSKINESIA 10 0.0002
883 ACCIDENTAL OVERDOSE 9 0.0002
884 CEREBRAL INFARCTION 6 0.0002
885 INJURY ASSOCIATED WITH DEVICE 5 0.0002
886 ASPARTATE AMINOTRANSFERASE INCREASED 13 0.0002
887 LIVER INJURY 6 0.0002
888 EYE DISORDER 8 0.0002
889 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
890 CYTOMEGALOVIRUS INFECTION 4 0.0002
891 COAGULOPATHY 4 0.0002
892 OEDEMA 13 0.0002
893 KNEE ARTHROPLASTY 5 0.0002
894 TOXICITY TO VARIOUS AGENTS 40 0.0002
895 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
896 HEPATITIS 6 0.0002
897 SKIN ULCER 6 0.0002
898 DEVICE USE ISSUE 4 0.0002
899 ALANINE AMINOTRANSFERASE INCREASED 14 0.0002
900 CARDIAC DISORDER 21 0.0002
901 DRUG-INDUCED LIVER INJURY 7 0.0002
902 OEDEMA PERIPHERAL 27 0.0002
903 NO ADVERSE EVENT 40 0.0002
904 PRODUCT AVAILABILITY ISSUE 5 0.0002
905 DYSURIA 8 0.0002
906 DEVICE MALFUNCTION 15 0.0002
907 ACNE 16 0.0002
908 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
909 RED BLOOD CELL COUNT DECREASED 6 0.0002
910 RECTAL HAEMORRHAGE 9 0.0002
911 BLOOD PRESSURE FLUCTUATION 5 0.0002
912 DIABETIC KETOACIDOSIS 5 0.0002
913 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
914 DRUG ABUSE 17 0.0002
915 EXTRA DOSE ADMINISTERED 8 0.0002
916 UNRESPONSIVE TO STIMULI 5 0.0002
917 RESPIRATORY FAILURE 14 0.0002
918 BONE DENSITY DECREASED 6 0.0002
919 COMA 9 0.0002
920 INTENTIONAL OVERDOSE 12 0.0002
921 HIP FRACTURE 6 0.0002
922 DRUG EFFECT DECREASED 10 0.0002
923 INJURY 13 0.0002
924 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
925 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
926 DEVICE LEAKAGE 8 0.0002
927 VAGINAL HAEMORRHAGE 8 0.0002
928 PALLOR 5 0.0002
929 DEVICE DELIVERY SYSTEM ISSUE 5 0.0002
930 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
931 DRUG DOSE OMISSION 30 0.0002
932 RESPIRATORY DISTRESS 5 0.0002
933 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
934 HEART RATE IRREGULAR 4 0.0002
935 DISORIENTATION 7 0.0002
936 HAEMOGLOBIN DECREASED 18 0.0002
937 ANAEMIA 33 0.0002
938 LIVER FUNCTION TEST ABNORMAL 5 0.0002
939 PRODUCT STORAGE ERROR 15 0.0002
940 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 8 0.0002
941 LUNG NEOPLASM MALIGNANT 7 0.0002
942 PSYCHOTIC DISORDER 5 0.0002
943 DISEASE RECURRENCE 8 0.0002
944 RENAL IMPAIRMENT 14 0.0002
945 BLOOD GLUCOSE DECREASED 8 0.0002
946 ILL-DEFINED DISORDER 10 0.0002
947 ADVERSE EVENT 15 0.0002
948 HAEMORRHAGE 17 0.0002
949 HYPOACUSIS 7 0.0002
950 FEMUR FRACTURE 5 0.0002
951 DRUG WITHDRAWAL SYNDROME 14 0.0002
952 CARDIOVASCULAR DISORDER 4 0.0002
953 ANAPHYLACTIC SHOCK 4 0.0002
954 HYPOKALAEMIA 7 0.0002
955 ABNORMAL BEHAVIOUR 6 0.0002
956 FEBRILE NEUTROPENIA 10 0.0002
957 RENAL DISORDER 7 0.0002
958 URINARY RETENTION 5 0.0001
959 HYPERKALAEMIA 5 0.0001
960 HYPONATRAEMIA 8 0.0001
961 DEVICE EXPULSION 9 0.0001
962 SEPTIC SHOCK 6 0.0001
963 HYPERGLYCAEMIA 5 0.0001
964 OVERDOSE 29 0.0001
965 BLOOD GLUCOSE INCREASED 25 0.0001
966 CORONARY ARTERY DISEASE 4 0.0001
967 DISEASE PROGRESSION 15 0.0001
968 ARRHYTHMIA 6 0.0001
969 MEDICATION ERROR 7 0.0001
970 NEOPLASM MALIGNANT 8 0.0001
971 DELIRIUM 4 0.0001
972 DEVICE DISLOCATION 5 0.0001
973 CEREBRAL HAEMORRHAGE 4 0.0001
974 BLOOD CREATININE INCREASED 7 0.0001
975 INTERSTITIAL LUNG DISEASE 5 0.0001
976 ATRIAL FIBRILLATION 10 0.0001
977 LEUKOPENIA 5 0.0001
978 THROMBOCYTOPENIA 11 0.0001
979 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
980 DRUG DEPENDENCE 15 0.0001
981 MALIGNANT NEOPLASM PROGRESSION 9 0.0001
982 PLATELET COUNT DECREASED 9 0.0001
983 PLEURAL EFFUSION 5 0.0001
984 CARDIAC FAILURE CONGESTIVE 6 0.0001
985 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
986 BREAST CANCER 6 0.0001
987 CARDIAC FAILURE 5 0.0001
988 CARDIAC ARREST 4 0.0000
989 DEATH 35 0.0000
990 NEUTROPENIA 5 0.0000